Seiichi Nurimoto

Title: Seiichi Nurimoto: Innovator in Pharmaceutical Chemistry

Introduction

Seiichi Nurimoto is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to advancements in analgesic agents, showcasing his expertise and innovative spirit.

Latest Patents

Nurimoto holds a patent for a novel azabicyclo octane derivative and the process for preparing the same. The compound is characterized by the formula where R¹ can be hydrogen, phenyl, alkyl of one to five carbon atoms, cycloalkyl of three to four carbon atoms, or alkyl of one to five carbon atoms with specific substituents. R² is either hydrogen or an alkyl of one to three carbon atoms, while R³ can be hydrogen, alkanoyl of two to six carbon atoms, benzoyl, or nicotinoyl. This compound and its pharmaceutically acceptable acid addition salt are recognized for their utility as analgesic agents.

Career Highlights

Seiichi Nurimoto is associated with Tanabe Seiyaku Company, Limited, where he has been instrumental in research and development. His innovative approach has led to the creation of compounds that have potential therapeutic benefits, particularly in pain management.

Collaborations

Nurimoto has collaborated with esteemed colleagues such as Mikio Takeda and Hirozumi Inoue. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Seiichi Nurimoto's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key inventor in the field. His work continues to influence the development of effective analgesic agents, showcasing the importance of innovation in healthcare.